CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental immune therapy aims to tame severe transplant complication
Disease control Recruiting nowThis early-stage trial tests a new treatment for people with chronic graft-versus-host disease (cGVHD) that hasn't responded to standard steroids. The treatment uses special immune cells (Treg cells) from the original stem cell donor, combined with a low dose of interleukin-2, to…
Matched conditions: CGVHD
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 06:35 UTC
-
New combo therapy aims to tame stubborn transplant complication
Disease control Recruiting nowThis study tests whether combining the drug axatilimab with a blood-filtering treatment called ECP can help people with chronic graft-versus-host disease (cGVHD), a condition where donor immune cells attack the recipient's body after a stem cell transplant. About 49 participants …
Matched conditions: CGVHD
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 26, 2026 06:30 UTC
-
New drug aims to stop deadly immune attack after stem cell transplant
Disease control Recruiting nowThis study tests an experimental drug called BPC2001 to prevent acute graft-versus-host disease (aGVHD) in 50 adults receiving a half-matched stem cell transplant for blood cancers. Participants get BPC2001 plus standard care, and researchers track how many develop aGVHD by day 1…
Matched conditions: CGVHD
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New cell shot targets stubborn transplant complication
Disease control Recruiting nowThis early-stage study tests a new cell therapy called GT729 for people with chronic graft-versus-host disease (cGVHD) that hasn't improved with standard treatments. cGVHD is a condition where donor immune cells attack the patient's body after a stem cell transplant. The study wi…
Matched conditions: CGVHD
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New study tracks 1,500 transplant patients to unlock secrets of chronic GVHD
Knowledge-focused Recruiting nowThis study follows 1,500 adults who recently received a stem cell transplant and are at risk for chronic Graft-Versus-Host Disease (cGVHD), a condition where donor cells attack the patient's body. Researchers will collect data on how often cGVHD occurs, how severe it is, and what…
Matched conditions: CGVHD
Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC